Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer

NCT01839773 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IV Gastric Cancer

Interventions

DRUG: Paclitaxel
DRUG: Paclitaxel

Sponsor

Daehwa Pharmaceutical Co., Ltd.